AMETEK, Inc. (NYSE:AME) Director Elizebeth R. Varet sold 4,050 shares of AMETEK stock in a transaction on Saturday, September 7th. The shares were sold at an average price of $78.65, for a total value of $318,532.50. Following the completion of the transaction, the director now owns 104,810 shares of the company’s stock, valued at $8,243,306.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.
NYSE:AME opened at $78.77 on Thursday. The firm has a market capitalization of $17.95 billion, a P/E ratio of 23.94, a P/E/G ratio of 2.02 and a beta of 1.20. AMETEK, Inc. has a 12-month low of $63.14 and a 12-month high of $81.92. The company has a quick ratio of 0.96, a current ratio of 1.46 and a debt-to-equity ratio of 0.54.
AMETEK (NYSE:AME) last announced its quarterly earnings results on Tuesday, February 5th. The technology company reported $0.86 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.84 by $0.02. The company had revenue of $1.27 billion during the quarter, compared to the consensus estimate of $1.26 billion. AMETEK had a return on equity of 17.72% and a net margin of 16.05%. AMETEK’s revenue for the quarter was up 11.1% on a year-over-year basis. During the same period in the previous year, the business earned $0.70 EPS. Equities research analysts predict that AMETEK, Inc. will post 3.92 earnings per share for the current year.
A number of hedge funds and other institutional investors have recently made changes to their positions in the business. GAM Holding AG acquired a new stake in shares of AMETEK during the third quarter worth about $516,000. Resources Management Corp CT ADV acquired a new stake in shares of AMETEK during the third quarter worth about $776,000. Diversified Trust Co increased its position in shares of AMETEK by 12.8% during the fourth quarter. Diversified Trust Co now owns 3,849 shares of the technology company’s stock worth $261,000 after purchasing an additional 436 shares in the last quarter. Vanguard Group Inc. increased its position in shares of AMETEK by 0.6% during the third quarter. Vanguard Group Inc. now owns 23,495,237 shares of the technology company’s stock worth $1,858,943,000 after purchasing an additional 137,102 shares in the last quarter. Finally, Forte Capital LLC ADV increased its position in shares of AMETEK by 1.1% during the fourth quarter. Forte Capital LLC ADV now owns 91,626 shares of the technology company’s stock worth $6,203,000 after purchasing an additional 973 shares in the last quarter. 85.24% of the stock is owned by institutional investors.
AME has been the subject of a number of recent research reports. ValuEngine lowered AMETEK from a “buy” rating to a “hold” rating in a report on Tuesday, October 23rd. BMO Capital Markets decreased their target price on AMETEK from $93.00 to $91.00 and set an “outperform” rating for the company in a report on Friday, November 2nd. Robert W. Baird lifted their target price on AMETEK from $82.00 to $84.00 and gave the company an “outperform” rating in a report on Friday, November 2nd. Morgan Stanley decreased their target price on AMETEK from $84.00 to $81.00 and set an “equal weight” rating for the company in a report on Monday, November 5th. Finally, Stephens initiated coverage on AMETEK in a report on Monday, November 19th. They issued an “overweight” rating and a $87.00 target price for the company. Twelve equities research analysts have rated the stock with a buy rating, The company presently has an average rating of “Buy” and a consensus target price of $86.10.
AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices worldwide. Its Electronic Instruments Group segment offers advanced instruments for the process, power and industrial, and aerospace markets; process and analytical instruments for the oil, gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage markets; and instruments for the laboratory equipment, ultraprecision manufacturing, medical, and test and measurement markets.
Featured Article: Market Capitalization in the Stock Market
Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.